spa-s-843 and Mycoses

spa-s-843 has been researched along with Mycoses* in 1 studies

Reviews

1 review(s) available for spa-s-843 and Mycoses

Article	Year
SPK-843 (Aparts/Kaken). Current opinion in investigational drugs (London, England : 2000), 2005, Volume: 6, Issue:8 SPK-843 is a water-soluble antibiotic under co-development by Aparts and Kaken for the potential treatment of systemic fungal infections. By November 2004, SPK-843 was in phase II trials for systemic mycosis. Topics: Animals; Antifungal Agents; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Humans; Mycoses; Patents as Topic; Polyenes; Structure-Activity Relationship	2005

Article

Year

Current opinion in investigational drugs (London, England : 2000), 2005, Volume: 6, Issue:8

SPK-843 is a water-soluble antibiotic under co-development by Aparts and Kaken for the potential treatment of systemic fungal infections. By November 2004, SPK-843 was in phase II trials for systemic mycosis.

Topics: Animals; Antifungal Agents; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Humans; Mycoses; Patents as Topic; Polyenes; Structure-Activity Relationship

2005